ORIC Pharmaceuticals, Inc. (DUS:4TZ) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carl Gordon Other companies: ADARx Pharmaceuticals, Inc. (Co-head Global Private Equity at OrbiMed Advisors · Since at least Sep 24, 2026); Electra Therapeutics, Inc. (Director · Since at least Sep 18, 2026); BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); Scribe Therapeutics Inc. (Director · Since at least Jul 23, 2026); Compass Therapeutics, Inc. (Founding Member, Managing Partner, and Co-Head of Global Private Equity, OrbiMed Advisors LLC · Since at least Jun 17, 2020); Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); MBX Biosciences, Inc. (Director · Sep 12, 2024 – Feb 14, 2025 · Past); ArriVent BioPharma, Inc. (Director · Jan 25, 2024 – Jan 30, 2024 · Past); Theseus Pharmaceuticals Inc (Director · Oct 6, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Terns Pharmaceuticals, Inc. (Director · Feb 4, 2021 – Jul 15, 2024 · Past); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Adicet Bio, Inc. (Director · Sep 15, 2020 – Aug 21, 2024 · Past); SpringWorks Therapeutics Inc (Director · Sep 12, 2019 – Sep 12, 2019 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 15, 2020 · Past); Alector, Inc. (Director · Feb 6, 2019 – May 10, 2019 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 27, 2016 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – May 18, 2017 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Sep 18, 2013 · Past); Pacira BioSciences, Inc. (Director · Feb 2, 2011 – Feb 8, 2011 · Past); Amarin Corporation plc (Director · Dec 30, 2010 – Sep 4, 2012 · Past); BioCryst Pharmaceuticals, Inc. (Director · May 17, 2006 – May 17, 2006 · Past) | Director · Apr 23, 2020 – Jun 16, 2021 · Past |
| Richard Heyman Other companies: Enliven Therapeutics, Inc. (Director · Since at least Feb 23, 2023); PMV Pharmaceuticals, Inc. (Director · Since at least Sep 24, 2020); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Kineta Inc. (Director · Dec 22, 2020 – Jun 2, 2021 · Past); Metacrine Inc (Director · Sep 15, 2020 – May 18, 2022 · Past); Tango Therapeutics, Inc. (Director · Sep 2, 2020 – Sep 2, 2020 · Past); Gritstone bio, Inc. (Director · Sep 27, 2018 – Jun 17, 2022 · Past) | Chairman · Since at least Apr 23, 2020 |
| Mardi C. Dier Other companies: Madrigal Pharmaceuticals, Inc. (EVP and CFO · Since at least Mar 11, 2024); Prelude Therapeutics Incorporated (Director · Since at least Sep 24, 2020); Acelyrin, Inc. (CFO and CBO · May 4, 2023 – May 9, 2023 · Past); Ultragenyx Pharmaceutical Inc. (CFO & Executive Vice President · Oct 12, 2020 – Oct 14, 2022 · Past); Adamas Pharmaceuticals Inc (Director · Oct 10, 2017 – Jun 2, 2021 · Past); Portola Pharmaceuticals Inc (EVP and CFO · May 21, 2013 – Jul 2, 2020 · Past) | Board Member · Since at least Apr 23, 2020 |
| Richard H. Scheller Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Alector, Inc. (Board Member · Since at least Feb 6, 2019); 23Andme Holding Co (Director · Jun 16, 2021 – Aug 26, 2024 · Past); BridgeBio Pharma, Inc. (Director · Jun 27, 2019 – Feb 16, 2023 · Past); Xenon Pharmaceuticals Inc. (Director · Mar 16, 2015 – Sep 16, 2019 · Past); Genentech Inc (EVP-RESEARCH · Jan 13, 2006 – Mar 26, 2009 · Past) | Director · Apr 23, 2020 – May 20, 2021 · Past |
| Steve L. Hoerter Other companies: MBX Biosciences, Inc. (Chairman, President and CEO, Director · Since at least Apr 7, 2025); C4 Therapeutics, Inc. (Director · Since at least Nov 19, 2024); Constellation Pharmaceuticals Inc (Director · Sep 4, 2018 – Jul 15, 2021 · Past); Deciphera Pharmaceuticals LLC (President and CEO, Director · May 17, 2018 – Jun 11, 2024 · Past); Agios Pharmaceuticals, Inc. (Chief Commercial Officer · Feb 16, 2016 – Mar 1, 2019 · Past); Clovis Oncology Inc (See Remarks · Nov 15, 2011 – Mar 5, 2015 · Past) | Board Member, Chairman and CEO of MBX Biosciences · Since at least Aug 13, 2021 |
| Lori Kunkel Other companies: Enliven Therapeutics, Inc. (Director · Since at least Apr 8, 2024); Nurix Therapeutics, Inc. (Director · Jul 23, 2020 – May 19, 2025 · Past); Tocagen Inc (Director · Jun 21, 2018 – Oct 4, 2019 · Past); Curis, Inc. (Director · Jan 22, 2018 – Jan 31, 2022 · Past); Loxo Oncology Inc (Director · Nov 2, 2017 – Feb 15, 2019 · Past) | Director · Since at least Jun 9, 2020 |
| Peter Svennilson Other companies: RAPT Therapeutics Inc (Director · Jun 18, 2020 – May 28, 2021 · Past); Revolution Medicines, Inc. (Director · Jun 17, 2020 – Apr 26, 2021 · Past); Gritstone bio, Inc. (Director · Jun 19, 2019 – Jun 19, 2019 · Past); NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 8, 2020 · Past) | Director · Apr 23, 2020 – Jun 16, 2021 · Past |
| Angie You Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Sierra Oncology Inc (Chief Bus. & Strat. Officer · Jul 15, 2015 – Mar 6, 2018 · Past) | Director · Since at least Nov 9, 2021 |
| Pratik Multani Other companies: Erasca, Inc. (Director · Since at least Jul 15, 2021); Chimerix Inc (Director · Feb 21, 2020 – Apr 21, 2025 · Past); Fate Therapeutics, Inc. (Chief Medical Officer · Sep 30, 2013 – Jan 5, 2015 · Past) | Chief Medical Officer · Since at least Apr 23, 2020 |
| Jacob Chacko Other companies: 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020) | PRESIDENT AND CEO, Director · Since at least Feb 1, 2021 |
| Christian V. Kuhlen | General Counsel and Chief Compliance Officer · Since at least Nov 5, 2026 |
| Dan Iazzetti | Vice President, Head of People · Since at least Nov 5, 2026 |
| Dominic Piscitelli | Chief Financial Officer · Since at least Jul 20, 2022 |
| Edna Chow Maneval | Executive Vice President, Clinical Development · Since at least Nov 5, 2026 |
| Keith Lui | Senior Vice President, Commercial and Medical Affairs · Since at least Feb 18, 2025 |
| Kevin Brodbeck | newly established role of Chief Technical Officer · Since at least Nov 13, 2025 |
| Lori Friedman | Chief Scientific Officer · Since at least Oct 23, 2026 |
| Matthew Panuwat | Chief Business Officer · Since at least Nov 5, 2026 |